— Know what they know.
Not Investment Advice

A

Agilent Technologies, Inc.
1W: -0.2% 1M: -11.9% 3M: -18.6% YTD: -19.2% 1Y: -8.4% 3Y: -15.2% 5Y: -7.3%
$111.30
-0.45 (-0.40%)
After Hours: $111.50 (+0.20, +0.18%)
NYSE · Healthcare · Medical - Diagnostics & Research · $31.5B · Alpha Radar Sell · Power 36
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$31.5B
52W Range96.43-160.27
Volume4,402,284
Avg Volume2,185,277
Beta1.31
Dividend$1.00
Analyst Ratings
29 Buy 8 Hold 1 Sell
Consensus Buy
Company Info
CEOPadraig McDonnell
Employees17,900
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date1999-11-18
5301 Stevens Creek Boulevard
Santa Clara, CA 95051
US
800 227 9770
About Agilent Technologies, Inc.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Recent Insider Trades

NameTypeSharesPriceDate
Henson Meghan 4,891 $116.98 2026-03-31
RIEMANN ANGELICA F-InKind 89 $121.38 2026-02-27
MCDONNELL PADRAIG F-InKind 279 $121.38 2026-02-27
KIRKWOOD JONAH PREVO F-InKind 124 $121.38 2026-02-27
Dolsten Mikael S-Sale 2,600 $149.81 2025-12-01

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms